Arcturus Therapeutics specializes in mRNA medicines, targeting infectious diseases and rare disorders using proprietary technologies. Despite a financial dip post-Q2 2023, Arcturus remains financially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results